Home › Scleroderma › Florida › Plantation
Scleroderma clinical trials in Plantation, FL
4 studies for Scleroderma are looking for participants at sites in and around Plantation (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
RecruitingPhase 3
- Integral Rheumatology and Immunology Specialist, Plantation
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
RecruitingPhase 2
- IRIS Research and Development LLC, Plantation
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
- Nkarta Investigational Site, Plantation
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Plantation, Plantation
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Ann Arbor, MI10 studies
- Chicago, IL10 studies
- Houston, TX9 studies
- Boston, MA7 studies
- Durham, NC7 studies
- Los Angeles, CA7 studies
- New Orleans, LA6 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- Dallas, TX5 studies
- Pittsburgh, PA5 studies
Other studies in Plantation
- Non-Small Cell Lung Cancer16 studies
- Breast Cancer14 studies
- Lupus7 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Rheumatoid Arthritis6 studies
- Metastatic Cancer6 studies
- Colorectal Cancer5 studies
- Psoriatic Arthritis5 studies
- Prostate Cancer5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Multiple Myeloma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.